Clinical Trials Logo

Clinical Trial Summary

Diverticular bleeding is the most common cause of acute lower gastrointestinal bleeding (LGIB) in Western populations. Although self-limited in 85% of cases, some patients may require hospitalization with blood transfusion and emergent intervention, with significant associated morbidity and mortality. Up to 25% of patients with an initial bleeding episode will have subsequent episodes.

Diverticula form at weak points along the colon wall, where the vasa recta enter the circular muscle layer of the colon. Diverticular bleeding is attributed to thinning of the blood vessels as they cross over the dome of a diverticulum. Endoscopic clipping of actively bleeding colonic diverticula has been recognized as a safe and effective treatment for acute LGIB since the mid1990s. Patients selected would have had previous colonoscopy to exclude other causes of bleeding (e.g. angiodysplasia, colorectal cancer).

The investigators propose prophylactic elective endoscopic diverticular clipping in patients who have had at least 1 episode of acute LGIB requiring hospitalization. This would involve applying endoscopic clips to the base of every diverticula in a patient's colon, such that any bleeding source would effectively be excluded. The investigators would later reevaluate patients for colonoscopic appearance of diverticula to assess their diverticular disease.

The investigators hypothesize that patients undergoing endoscopic diverticular clipping will not have repeat episodes of bleeding.


Clinical Trial Description

1.0 BACKGROUND AND HYPOTHESES

The investigators aim to prophylactically clip all colonic diverticula in patients who have experienced at least 1 episode of diverticular bleeding requiring hospitalization, but without definitive procedure (i.e., total colectomy or localization with embolization or clipping). The investigators' objective is to prevent future episodes of colonic bleeding from the diverticula, so as to avoid morbidity and possible mortality.

The investigators hypothesize that those patients undergoing secondary prophylaxis through diverticular clipping will experience no further episodes of diverticular bleeding.

2.0 OBJECTIVES AND PURPOSE

Diverticular bleeding is the most common cause of acute lower gastrointestinal bleeding (LGIB) in Western populations. Although self-limited in 85% of cases, some patients may require hospitalization with blood transfusion and emergent intervention, with significant associated morbidity and mortality. Up to 25% of patients with an initial bleeding episode will have subsequent episodes.

Diverticula form at weak points along the colon wall, where the vasa recta enter the circular muscle layer of the colon. Diverticular bleeding is attributed to thinning of the blood vessels as they cross over the dome of a diverticulum. Endoscopic clipping of actively bleeding colonic diverticula has been recognized as a safe and effective treatment for acute LGIB since the mid-1990s. Patients selected would have had previous colonoscopy to exclude other causes of bleeding (e.g. angiodysplasia, colorectal cancer).

The investigators propose prophylactic elective endoscopic diverticular clipping in patients who have had at least 1 episode of acute LGIB requiring hospitalization. This would involve applying endoscopic clips to the base of every diverticula in a patient's colon, such that any bleeding source would effectively be excluded. The investigators would later re-evaluate patients for colonoscopic appearance of diverticula, as there is some suggestion that diverticula may resolve after such management.

3.0 STUDY DESIGN

The investigators propose a prospective feasibility study of outpatients who have previously been hospitalized with at least one episode of diverticular bleeding. Diverticular disease will have been confirmed by previous colonoscopy to assess the extent of diverticular disease. Consecutive patients at follow-up outpatient appointments will be approached with a Patient Information Sheet. On follow-up appointment they will be recruited and enrolled for endoscopic clipping of colonic diverticula.

The procedure itself will be similar to a screening colonoscopy. As outpatients, patients will take bowel preparation. Colonoscopy will occur with sedation only, including fentanyl and midazolam per protocol. Individual colonic diverticula will be clipped to exclude the bleeding source.

Twenty-four (24) patients will be enrolled for diverticular clipping. These patients will be followed prospectively for 2 years for repeat bleeding episodes. Follow-up will consist of telephone calls every 6 months by the study team. In addition, patients will be scheduled for repeat colonoscopy to assess their diverticular disease 6 months after clipping of colonic diverticula.

4.0 SELECTION AND WITHDRAWAL OF SUBJECTS Currently, patients admitted with complications of diverticular disease are seen in Diverticular Disease clinic for follow-up. Consecutive patients will be selected from this patient population.

Patients may withdrawal from the study at any time, including during the colonoscopy with clipping of diverticula.

5.0 DATA COLLECTION AND MONITORING

Data collection will take place on a specially created case report form (See case report form version 1.2). Case report forms will be stored in a locked office in the Department of Colorectal Surgery accessible only to the study team. Data will be entered into an excel spreadsheet. The spreadsheet will be kept on a password protected NHS desktop in a locked office in the Department of Colorectal Surgery.

6.0 STATISTICAL CONSIDERATIONS

As this is a feasibility study, recruited patients will be study prospectively. Any analysis will include all patients enrolled. There will be no control group or randomization at this time. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02094456
Study type Interventional
Source King's College Hospital NHS Trust
Contact
Status Completed
Phase N/A
Start date April 1, 2016
Completion date May 5, 2018

See also
  Status Clinical Trial Phase
Completed NCT03935100 - Prophylactic Endoscopic Clipping of Diverticula (PECoD) N/A
Completed NCT01120340 - Evaluation of Efficacy of Mesalamine in the Long-term Prevention of Diverticulitis Flares Phase 3
Recruiting NCT02598414 - The Role of Indocyanine Green (ICG) Fluorescence Imaging on Anastomotic Leak in Robotic Colorectal Surgery Phase 2/Phase 3
Completed NCT02068482 - Immunohistology in USDD and Correlation Between Bacterial Flora and Phlogosis Phase 4
Completed NCT04173182 - Confocal Laser Endomicrospy in Colonic Diverticular Disease
Completed NCT02849717 - Pre-Habilitation Exercise Intervention N/A
Withdrawn NCT02221713 - The Gut Microbiome in Diverticulitis and Diverticulosis
Recruiting NCT03490279 - Lactoferrin for the Treatment of Symptomatic Uncomplicated Diverticular Disease N/A
Recruiting NCT02500992 - Bacterial Contamination in Transrectal Hybrid NOTES Sigmoidectomy N/A
Recruiting NCT01626963 - Single-port Versus Conventional Laparoscopic Colorectal Surgery Phase 1/Phase 2
Completed NCT02278770 - DD Obesity MRI Study N/A
Recruiting NCT00747292 - Peri-Operative Management of Patients Undergoing Laparoscopic Colorectal Surgery Phase 1/Phase 2
Completed NCT02115867 - Effect of a Probiotic on Diverticular Symptoms Phase 3
Terminated NCT03455751 - Precision Pain Management for Major Abdominal Surgery in Colorectal Surgery N/A